Found 307 results for oasmia-pharmaceutical

Lucite tombstone marking a follow-on offering by RXi Pharmaceuticals, a biotech firm based in Marlborough, Massachusetts.

Pyramid-shaped deal toy commemorating convertible notes issued by Ligand Pharmaceuticals, based in San Diego. Goldman Sachs and Barclays acted as Joint Book-Running Managers for the issue.

Custom crystal tombstone marking a private placement by Swiss biopharmaceutical company Auris Medical. Ladenburg Thalmann acted as exclusive placement agent.

Custom crystal tombstone marking a private placement by Rezolute, a California-based clinical stage biopharmaceutical firm.

Custom financial tombstone recognizing a follow-on offering by Turning Point Therapeutics. Turning Point is a clinical-stage biopharmaceutical company focused on oncology therapies.

Custom deal tombstone celebrating the initial public offering by Rameda, Pharmaceuticals, a Cairo-based generic drug firm.

Custom deal toy commemorating the initial public offering of CNS Pharmaceuticals, a Houston-based, pre-clinical stage biotech firm specializing in the treatment of brain tumors.

Lucite tombstone marking the acquisition of Catalyst Regulatory Services, which provides regulatory support for biopharmaceutical firms.

Crystal deal toy commemorating a loan facility provided for Biohaven Pharmaceuticals, based in New Haven, Connecticut.